BIVDA Press Releases

02Mar

UK Summit calls for hard evidence on In-Vitro Diagnostics

The 2nd annual UK Diagnostics Summit will take place yet again on November 8th this time at The Strand Palace Hotel, London. The Summit, which is supported by BIVDA, will build on the success of 2017 and further accelerate learning around the benefits of In-Vitro Diagnostics in both Primary and Secondary Care settings.

For 2018 the organisers, 4 All of us, are requesting Oral and Poster submissions from BIVDA members which demonstrate the impact In-Vitro Diagnostics is having across the UK and Europe. This week, 4 All of us and NHS England’s UK AMR Diagnostics Collaborative held a Workshop for CCG’s, GP’s and Trusts to start building a national overview of CRP & POC usage in the UK. The workshop findings will be showcased on the 8th November and 4 All of us are keen to ensure Industry fulfils its important role by highlight its best-practice.

Speaking about the Summit, Conference Director, Scott Buckler said;

“I am fully aware of the current frustrations amongst Industry providers in relation to national direction around the use of In-Vitro Diagnostics in the UK. Much of this frustration is due to a lack of top-down action and leadership within healthcare. However, there is action being taken by Government and bodies like BIVDA to accelerate progress, but its important we see data and results from Industry to ensure the argument is stronger. Lets not sit on the data, lets not be frightened that our competitors may see it, we need Industry to work together to see a change.”

“We are all aware of the barriers to take up of In-Vitro Diagnostics, yet we must address these collectively between health professionals and industry leaders to collaborate an approach which will see diagnostics utilised in prevention and support the NHS long-term sustainability as well as improve patient care.”

To submit a presentation for consideration or a Poster, please visit www.ukdiagnosticssummit.com and click on Conference section. All presentations will be considered by both 4 All of us and BIVDA. Deadline for submissions is June 1st.

Early bird tickets and discounts for BIVDA members are in place.

Related

BIVDA Launches IVD Value Story

The British In Vitro Diagnostics Association (BIVDA) has today (25 October) launched its new report ...

Read More >

BIVDA’s Response to the 2017 General Election Result

Commenting on the result of the Election, BIVDA’s Chief Executive Doris-Ann Williams MBE said: “...

Read More >

BIVDA publishes report looking at the point of care testing environment in the UK

BIVDA has today published a report looking at the findings of its survey of point of care coordinato...

Read More >

UK Continues to Lag EU Market for In-Vitro Diagnostic Expenditure

The European IVD Market Statistics Report 2016 has been published by MedTech Europe and is available...

Read More >

BIVDA comment on the Health and Social Care Committee’s report into Antimicrobial resistance

Today the Health and Social Care Committee has published its report on Antimicrobial resistance.

Read More >

BIVDA Response to the Life Sciences Sector Deal

Commenting on the publication of the Life Sciences Sector Deal (6th December 2017), BIVDA’s Chief E...

Read More >